Management of Acute Agitation in Bipolar and Schizophrenia Patients

Rationale for Medication Selection

The American College of Emergency Physicians recommends lorazepam 1 mg PRN as the most appropriate medication for acute agitation in patients with bipolar disorder and schizophrenia, due to its efficacy in reducing agitation scores at 30, 60, and 120 minutes after administration 1
For patients with severe agitation and distress related to delusions, lorazepam can be administered at 1 mg subcutaneously or intravenously (up to 2 mg maximum) as a crisis medication, providing flexibility in administration based on the patient's level of cooperation 2

The American College of Emergency Physicians suggests starting with 1 mg PRN (orally if the patient is cooperative; parenteral if not), with the option to administer as frequently as every hour if needed, though 4-8 hour intervals are often sufficient 1, 2
Lower doses (0.25-0.5 mg) may be appropriate if the patient is elderly, frail, or has respiratory conditions like COPD, due to the potential for excessive sedation 2, 3

Olanzapine has shown similar efficacy to haloperidol in treating agitation based on PANSS-EC scores, with both being superior to placebo, and may be considered as an alternative option for prompt control of acute agitation in schizophrenic patients with moderate to severe symptoms 1
Olanzapine 10 mg IM has demonstrated greater reduction in agitation scores at 2 hours compared to lorazepam 2 mg IM in bipolar mania, though by 24 hours there was no significant difference, highlighting the importance of individualized treatment plans 1

The patient's current medication regimen, including risperidone 0.5 mg and divalproex 250 mg, is appropriate but may require optimization, with consideration for gradual titration of risperidone up to 2-3 mg daily in divided doses if needed, and titration of divalproex to reach therapeutic blood levels (40-90 mcg/mL) 4
Adding lorazepam PRN is preferable to increasing antipsychotic doses acutely, as it addresses the immediate agitation while allowing time to optimize the standing medication regimen, and reduces the risk of excessive sedation and other adverse effects 1, 2

Monitor for excessive sedation, especially given the combination with risperidone and divalproex, and be aware of the potential for paradoxical agitation, which occurs in approximately 10% of patients treated with benzodiazepines 3, 4
Increased risk of falls, especially if the patient is elderly, highlights the importance of close monitoring and individualized care plans 2
Avoid regular, long-term use of benzodiazepines as this can lead to tolerance, addiction, and cognitive impairment, emphasizing the need for careful consideration of treatment duration and alternatives 4